Table of Content

1    INTRODUCTION    23
1.1    STUDY OBJECTIVES    23
1.2    MARKET DEFINITION    23
1.2.1    INCLUSIONS AND EXCLUSIONS    24
1.3    MARKETS COVERED    25
1.3.1    MARKET SEGMENTATION    25
1.3.2    REGIONAL SEGMENTATION    25
1.4    YEARS CONSIDERED    26
1.5    CURRENCY CONSIDERED    26
1.6    RESEARCH LIMITATIONS    26
1.7    STAKEHOLDERS    27
1.8    SUMMARY OF CHANGES    27
2    RESEARCH METHODOLOGY    28
2.1    RESEARCH DATA    28
FIGURE 1    NEAR INFRARED IMAGING MARKET: RESEARCH DESIGN    28
2.1.1    SECONDARY RESEARCH    29
2.1.2    PRIMARY RESEARCH    30
2.1.2.1    Primary sources    30
2.1.2.2    Key industry insights    31
2.1.2.3    Breakdown of primaries    32
FIGURE 2    BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY AND DEMAND SIDE PARTICIPANTS    32
FIGURE 3    BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION    32
2.2    MARKET SIZE ESTIMATION    32
FIGURE 4    RESEARCH METHODOLOGY: HYPOTHESIS BUILDING    33
2.2.1    BOTTOM-UP APPROACH    34
2.2.1.1    Approach 1: Company revenue estimation approach    34
FIGURE 5    APPROACH 1: MARKET SIZE ESTIMATION (COMPANY REVENUE ESTIMATION)    34
FIGURE 6    REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF STRYKER    35
2.2.1.2    Approach 2: Customer-based market estimation    35
FIGURE 7    NEAR-INFRARED IMAGING MARKET: BOTTOM-UP APPROACH    36
2.2.1.3    CAGR projections    36
FIGURE 8    CAGR PROJECTION: SUPPLY SIDE ANALYSIS    36
2.3    DATA TRIANGULATION    37
FIGURE 9    DATA TRIANGULATION METHODOLOGY    37
2.4    MARKET SHARE ASSESSMENT    38
2.5    STUDY ASSUMPTIONS    38
2.6    RISK ASSESSMENT    38
2.6.1    NEAR-INFRARED IMAGING MARKET: RISK ASSESSMENT    38
2.7    GROWTH RATE ASSUMPTIONS    39
2.8    NEAR-INFRARED IMAGING MARKET: RECESSION IMPACT    39
3    EXECUTIVE SUMMARY    40
FIGURE 10    NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)    40
FIGURE 11    NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)    41
FIGURE 12    NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023 VS. 2028 (USD MILLION)    42
FIGURE 13    NEAR-INFRARED IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)    43
FIGURE 14    GEOGRAPHICAL SNAPSHOT: NEAR-INFRARED IMAGING MARKET    44
4    PREMIUM INSIGHTS    45
4.1    NEAR-INFRARED IMAGING MARKET OVERVIEW    45
FIGURE 15    RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET    45
4.2    NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT (2023 VS. 2028)    46
FIGURE 16    DEVICES SEGMENT TO DOMINATE NORTH AMERICAN NEAR-INFRARED IMAGING MARKET DURING FORECAST PERIOD    46
4.3    ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY END USER (2023 VS. 2028)    46
FIGURE 17    HOSPITALS & SURGICAL CLINICS TO FORM LARGEST END USER SEGMENT IN ASIA PACIFIC MARKET    46
4.4    GLOBAL: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE (2023 VS. 2028)    47
FIGURE 18    FLUORESCENCE IMAGING SYSTEMS SEGMENT TO HOLD LARGEST SHARE DURING STUDY PERIOD    47
4.5    GEOGRAPHICAL SNAPSHOT OF NEAR-INFRARED IMAGING MARKET    47
FIGURE 19    CHINA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD    47
5    MARKET OVERVIEW    48
5.1    INTRODUCTION    48
5.2    MARKET DYNAMICS    48
FIGURE 20    NEAR-INFRARED IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    48
5.2.1    DRIVERS    49
5.2.1.1    Increasing number of surgical procedures globally    49
5.2.1.2    Advantages of near-infrared imaging over conventional visualization methods    50
TABLE 1    ADVANTAGES OF NEAR-INFRARED IMAGING OVER CONVENTIONAL VISUALIZATION METHODS    50
5.2.1.3    Technological advancements in near-infrared imaging modalities    50
5.2.1.4    Adoption of hybrid near-infrared imaging modalities for surgical guidance and molecular imaging    51
5.2.2    RESTRAINTS    51
5.2.2.1    Lengthy approval process of near-infrared fluorophores    51
5.2.2.2    High initial capital and operational costs of near-infrared systems    52
5.2.2.3    Availability of alternate technologies    52
5.2.3    OPPORTUNITIES    52
5.2.3.1    Growth potential for major players in emerging economies    52
5.2.3.2    Use of blockchain for distribution and storage of medical images    53
5.2.4    CHALLENGES    53
5.2.4.1    Hospital budget cuts    53
5.2.4.2    Dearth of trained professionals in emerging economies    53
5.3    PORTER’S FIVE FORCES ANALYSIS    54
TABLE 2    NEAR-INFRARED IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS    54
5.3.1    THREAT OF NEW ENTRANTS    55
5.3.2    THREAT OF SUBSTITUTES    55
5.3.3    BARGAINING POWER OF SUPPLIERS    55
5.3.4    BARGAINING POWER OF BUYERS    55
5.3.5    INTENSITY OF COMPETITIVE RIVALRY    55
5.4    REGULATORY ANALYSIS    56
5.4.1    NORTH AMERICA    56
5.4.1.1    US    56
TABLE 3    US: APPROVED IMAGING DEVICES BY FDA    56
TABLE 4    US FDA: MEDICAL DEVICE CLASSIFICATION    57
TABLE 5    US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS    57
5.4.1.2    Canada    58
TABLE 6    CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS    58
5.4.2    EUROPE    58
5.4.3    ASIA PACIFIC    59
5.4.3.1    Japan    59
TABLE 7    JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA    59
5.4.3.2    China    60
TABLE 8    CHINA: CLASSIFICATION OF MEDICAL DEVICES    60
5.4.3.3    India    61
5.5    REIMBURSEMENT SCENARIO ANALYSIS    61
TABLE 9    MEDICAL REIMBURSEMENT CPT CODES FOR NEAR-INFRARED PROCEDURES IN US (AS OF 2021)    62
5.6    ECOSYSTEM MAPPING    62
5.7    VALUE CHAIN ANALYSIS    63
5.7.1    RESEARCH & PRODUCT DEVELOPMENT    63
5.7.2    RAW MATERIAL AND MANUFACTURING    63
5.7.3    MARKETING & SALES, SHIPMENT, AND POST-SALES SERVICES    63
FIGURE 21    VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE    64

5.8    SUPPLY CHAIN ANALYSIS    64
5.8.1    PROMINENT COMPANIES    64
5.8.2    SMALL & MEDIUM-SIZED ENTERPRISES    64
5.8.3    END USERS    64
TABLE 10    SUPPLY CHAIN ECOSYSTEM OF NEAR-INFRARED IMAGING MARKET    65
FIGURE 22    NEAR-INFRARED IMAGING MARKET: SUPPLY CHAIN ANALYSIS    66
5.9    PATENT ANALYSIS    67
FIGURE 23    PATENT DETAILS FOR NEAR-INFRARED IMAGING (JANUARY 2013–MAY 2023)    67
FIGURE 24    PATENT DETAILS FOR NEAR-INFRARED FLUORESCENCE IMAGING SYSTEMS (JANUARY 2013–MAY 2023)    68
FIGURE 25    PATENT DETAILS FOR NEAR-INFRARED DYES (JANUARY 2013–MAY 2023)    69
5.10    TRADE ANALYSIS    70
5.10.1    TRADE ANALYSIS: NEAR-INFRARED IMAGING MARKET    70
TABLE 11    IMPORT DATA FOR NEAR-INFRARED IMAGING (HS CODE 902750), BY COUNTRY, 2018–2022 (USD)    70
TABLE 12    EXPORT DATA FOR NEAR-INFRARED IMAGING (HS CODE 902750), BY COUNTRY, 2018–2022 (USD)    70
5.11    KEY CONFERENCES AND EVENTS (2023–2025)    71
TABLE 13    NEAR-INFRARED IMAGING MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023–2025)    71
5.12    TECHNOLOGY ANALYSIS    72
5.13    CASE STUDY ANALYSIS    73
5.13.1    TECHNOLOGICAL CHALLENGES    73
TABLE 14    CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE    73
5.13.2    LOWERING DEPENDENCE ON CONTRACT MANUFACTURING    73
TABLE 15    CASE STUDY 2: PROVIDING TRAINING AND EDUCATION AND KEEPING UP WITH EVOLVING SURGICAL TECHNIQUES    73
5.14    PRICING ANALYSIS    74
TABLE 16    REGION-WISE PRICE RANGE FOR NEAR-INFRARED IMAGING SYSTEMS    74
6    NEAR-INFRARED IMAGING MARKET, BY PRODUCT    75
6.1    INTRODUCTION    76
TABLE 17    NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    76
6.2    DEVICES    76
TABLE 18    NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    76
TABLE 19    NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY REGION, 2021–2028 (USD MILLION)    77
TABLE 20    NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY APPLICATION, 2021–2028 (USD MILLION)    77
TABLE 21    NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)    78
TABLE 22    NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY END USER, 2021–2028 (USD MILLION)    78
6.2.1    FLUORESCENCE IMAGING SYSTEMS    78
6.2.1.1    Higher sensitivity and better real-time image guidance during surgeries to drive market    78
TABLE 23    FLUORESCENCE IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)    79
6.2.2    FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS    80
6.2.2.1    Better sensitivity and higher efficiency at lower costs to drive market    80
TABLE 24    FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)    80
6.3    NIR IMAGING AGENTS/PROBES    81
TABLE 25    NEAR-INFRARED IMAGING MARKET FOR NIR IMAGING AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    81
TABLE 26    NEAR-INFRARED IMAGING MARKET FOR NIR IMAGING AGENTS/PROBES, BY REGION, 2021–2028 (USD MILLION)    82
TABLE 27    NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY APPLICATION, 2021–2028 (USD MILLION)    82
TABLE 28    NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY PROCEDURE, 2021–2028 (USD MILLION)    83
TABLE 29    NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY END USER, 2021–2028 (USD MILLION)    83
6.3.1    INDOCYANINE GREEN    84
6.3.1.1    Increasing utilization of small organic probes in near-infrared imaging to drive segment    84
TABLE 30    INDOCYANINE GREEN MARKET, BY REGION, 2021–2028 (USD MILLION)    84
6.3.2    OTHER REAGENTS    85
6.3.2.1    Other reagents to provide specific functionalities and properties for better imaging process    85
TABLE 31    OTHER REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)    85
6.4    NIR DYES    85
TABLE 32    NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    86
TABLE 33    NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY REGION, 2021–2028 (USD MILLION)    86
TABLE 34    NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY APPLICATION, 2021–2028 (USD MILLION)    87
TABLE 35    NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY PROCEDURE, 2021–2028 (USD MILLION)    87
TABLE 36    NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY END USER, 2021–2028 (USD MILLION)    88
6.4.1    ORGANIC DYES    88
6.4.1.1    Unique molecular structure and better compatibility with biological systems to drive segment    88
TABLE 37    ORGANIC DYES MARKET, BY REGION, 2021–2028 (USD MILLION)    89
6.4.2    NANOPARTICLE DYES    89
6.4.2.1    Better brightness and enhanced signal intensity compared to organic dyes to drive segment    89
TABLE 38    NANOPARTICLE DYES MARKET, BY REGION, 2021–2028 (USD MILLION)    90
7    NEAR-INFRARED IMAGING MARKET, BY PROCEDURE    91
7.1    INTRODUCTION    92
TABLE 39    NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)    92
7.2    CANCER SURGERIES    92
TABLE 40    NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY TYPE, 2021–2028 (USD MILLION)    93
TABLE 41    NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY REGION, 2021–2028 (USD MILLION)    93
7.2.1    BRAIN CANCER/TUMOR SURGERIES    94
7.2.1.1    Advancements in surgical navigation using NIR-I/II fluorescence imaging to drive market    94
TABLE 42    BRAIN CANCER/TUMOR SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION)    94
7.2.2    OTHER CANCER SURGERIES    95
7.2.2.1    Better tissue penetration and lower autofluorescence levels to drive market    95
TABLE 43    OTHER CANCER SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION)    95
7.3    GASTROINTESTINAL SURGERIES    96
TABLE 44    NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES, BY TYPE, 2021–2028 (USD MILLION)    96
TABLE 45    NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES, BY REGION, 2021–2028 (USD MILLION)    97
7.3.1    COLORECTAL SURGERIES    97
7.3.1.1    Advancements in treatment strategies and procedures to drive market    97
TABLE 46    COLORECTAL SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION)    98
7.3.2    OTHER GASTROINTESTINAL SURGERIES    98
7.3.2.1    Precise visualization of near-infrared imaging to drive market    98
TABLE 47    OTHER GASTROINTESTINAL SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION)    99
7.4    CARDIOVASCULAR DISEASES    99
7.4.1    RISING PREVALENCE OF CARDIOVASCULAR DISEASES AMONG ALL AGE GROUPS TO DRIVE MARKET    99
TABLE 48    NEAR-INFRARED IMAGING MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION)    100
7.5    PLASTIC/RECONSTRUCTIVE SURGERIES    100
7.5.1    RISING NUMBER OF RECONSTRUCTIVE SURGERIES GLOBALLY TO DRIVE MARKET    100
TABLE 49    NEAR-INFRARED IMAGING MARKET FOR PLASTIC/RECONSTRUCTIVE SURGERIES, BY REGION, 2021–2028 (USD MILLION)    101
7.6    OBSTETRICS & GYNECOLOGY SURGERIES    101
7.6.1    INCREASED NUMBER OF CLINICAL TRIALS AND IMPROVED TISSUE CONTRAST DURING SURGERIES TO DRIVE MARKET    101
TABLE 50    NEAR-INFRARED IMAGING MARKET FOR OBSTETRICS & GYNECOLOGY SURGERIES, BY REGION, 2021–2028 (USD MILLION)    102
7.7    OTHER PROCEDURES    103
TABLE 51    NEAR-INFRARED IMAGING MARKET FOR OTHER PROCEDURES, BY REGION, 2021–2028 (USD MILLION)    103
8    NEAR-INFRARED IMAGING MARKET, BY APPLICATION    104
8.1    INTRODUCTION    105
TABLE 52    NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)    105
8.2    PRECLINICAL IMAGING    105
8.2.1    GROWING FOCUS ON DEVELOPING NEW TREATMENTS FOR CHRONIC DISEASES TO DRIVE MARKET    105
TABLE 53    NEAR-INFRARED IMAGING MARKET FOR PRECLINICAL IMAGING, BY REGION, 2021–2028 (USD MILLION)    106
8.3    CLINICAL IMAGING    106
8.3.1    INCREASING USE OF NEAR-INFRARED IMAGING FOR REAL-TIME VISUALIZATION DURING SURGERIES TO DRIVE MARKET    106
TABLE 54    NEAR-INFRARED IMAGING MARKET FOR CLINICAL IMAGING, BY REGION, 2021–2028 (USD MILLION)    107
8.4    MEDICAL IMAGING    107
8.4.1    APPLICATIONS OF FLUORESCENCE IMAGING SINGLE-CELL TRACKING FOR STUDYING IMMUNE SYSTEM TO DRIVE MARKET    107
TABLE 55    NEAR-INFRARED IMAGING MARKET FOR MEDICAL IMAGING, BY REGION, 2021–2028 (USD MILLION)    108
9    NEAR-INFRARED IMAGING MARKET, BY END USER    109
9.1    INTRODUCTION    110
TABLE 56    NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)    110
9.2    HOSPITALS & SURGICAL CLINICS    110
9.2.1    RISING NUMBER OF CANCER AND RECONSTRUCTIVE SURGERIES TO DRIVE MARKET    110
TABLE 57    NEAR-INFRARED IMAGING MARKET FOR HOSPITALS & SURGICAL CLINICS, BY REGION, 2021–2028 (USD MILLION)    111
9.3    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES    111
9.3.1    GROWING PRECLINICAL RESEARCH AND DRUG DISCOVERY TO DRIVE MARKET    111
TABLE 58    NEAR-INFRARED IMAGING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION)    112
9.4    RESEARCH LABORATORIES & ACADEMIC INSTITUTES    112
9.4.1    FUNDING FROM GOVERNMENT ORGANIZATIONS FOR BIOMEDICAL RESEARCH TO DRIVE MARKET    112
TABLE 59    NEAR-INFRARED IMAGING MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2021–2028 (USD MILLION)    113
9.5    OTHER END USERS    114
TABLE 60    NEAR-INFRARED IMAGING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)    114
10    NEAR-INFRARED IMAGING MARKET, BY REGION    115
10.1    INTRODUCTION    116
TABLE 61    NEAR-INFRARED IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)    116
10.2    NORTH AMERICA    117
FIGURE 26    NORTH AMERICA: NEAR-INFRARED IMAGING MARKET SNAPSHOT    117
TABLE 62    NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    118
TABLE 63    NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    118
TABLE 64    NORTH AMERICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    118
TABLE 65    NORTH AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    119
TABLE 66    NORTH AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    119
TABLE 67    NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)    119
TABLE 68    NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)    120
TABLE 69    NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)    120
10.2.1    US    121
10.2.1.1    Advanced healthcare infrastructure and favorable regulations to drive market    121
TABLE 70    US: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    121
TABLE 71    US: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    122
TABLE 72    US: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    122
TABLE 73    US: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    122
10.2.2    CANADA    123
10.2.2.1    Increased availability of research funding to drive market    123
TABLE 74    CANADA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    123
TABLE 75    CANADA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    124
TABLE 76    CANADA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    124
TABLE 77    CANADA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    124
10.3    EUROPE    125
TABLE 78    EUROPE: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    125
TABLE 79    EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    125
TABLE 80    EUROPE: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    126
TABLE 81    EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    126
TABLE 82    EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    126
TABLE 83    EUROPE: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)    127
TABLE 84    EUROPE: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)    127
TABLE 85    EUROPE: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)    128
10.3.1    GERMANY    128
10.3.1.1    Increasing healthcare expenditure and government spending to drive market    128
TABLE 86    GERMANY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    129
TABLE 87    GERMANY: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    129
TABLE 88    GERMANY: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    129
TABLE 89    GERMANY: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    130
10.3.2    FRANCE    130
10.3.2.1    Increasing target patient population and rising number of diagnostic tests for chronic diseases to drive market    130
TABLE 90    FRANCE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    131
TABLE 91    FRANCE: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    131
TABLE 92    FRANCE: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    131
TABLE 93    FRANCE: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    132
10.3.3    UK    132
10.3.3.1    Growing government initiatives and increasing incidences of chronic diseases to drive market    132
TABLE 94    UK: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    132
TABLE 95    UK: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    133
TABLE 96    UK: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    133
TABLE 97    UK: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    133
10.3.4    ITALY    134
10.3.4.1    Increased availability of reimbursement coverage for diagnostic procedures to drive market    134
TABLE 98    ITALY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    134
TABLE 99    ITALY: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    135
TABLE 100    ITALY: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    135
TABLE 101    ITALY: NEAR-INFRARED IMAGING MARKET FOR NIR DYE, BY TYPE, 2021–2028 (USD MILLION)    135
10.3.5    SPAIN    136
10.3.5.1    Increasing prevalence of cancer and growing private-public funding to drive market    136
TABLE 102    SPAIN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    136
TABLE 103    SPAIN: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    137
TABLE 104    SPAIN: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    137
TABLE 105    SPAIN: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    137
10.3.6    REST OF EUROPE    138
TABLE 106    REST OF EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    138
TABLE 107    REST OF EUROPE: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    138
TABLE 108    REST OF EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    139
TABLE 109    REST OF EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    139
10.4    ASIA PACIFIC    140
FIGURE 27    ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET SNAPSHOT    140
TABLE 110    ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    141
TABLE 111    ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    141
TABLE 112    ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    142
TABLE 113    ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    142
TABLE 114    ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    142
TABLE 115    ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)    143
TABLE 116    ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)    143
TABLE 117    ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)    144
10.4.1    CHINA    144
10.4.1.1    Increasing healthcare reforms and government investments to drive market    144
TABLE 118    CHINA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    145
TABLE 119    CHINA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    145
TABLE 120    CHINA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    145
TABLE 121    CHINA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    146
10.4.2    JAPAN    146
10.4.2.1    Fast adoption of advanced technologies and growth in geriatric population to drive market    146
TABLE 122    JAPAN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    147
TABLE 123    JAPAN: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    147
TABLE 124    JAPAN: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    148
TABLE 125    JAPAN: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    148
10.4.3    INDIA    148
10.4.3.1    Increasing number of diagnostic procedures and improving healthcare infrastructure to drive market    148
TABLE 126    INDIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    149
TABLE 127    INDIA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    149
TABLE 128    INDIA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    150
TABLE 129    INDIA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    150
10.4.4    AUSTRALIA    150
10.4.4.1    Growing healthcare spending and increasing investments in research to drive market    150
TABLE 130    AUSTRALIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    151
TABLE 131    AUSTRALIA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    151
TABLE 132    AUSTRALIA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    152
TABLE 133    AUSTRALIA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    152
10.4.5    SOUTH KOREA    152
10.4.5.1    Presence of advanced healthcare system and increased awareness about diseases to drive market    152
TABLE 134    SOUTH KOREA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    153
TABLE 135    SOUTH KOREA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    153
TABLE 136    SOUTH KOREA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    154
TABLE 137    SOUTH KOREA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    154
10.4.6    REST OF ASIA PACIFIC    154
TABLE 138    REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    155
TABLE 139    REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    155
TABLE 140    REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    156
TABLE 141    REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    156
10.5    LATIN AMERICA    157
TABLE 142    LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    157
TABLE 143    LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    157
TABLE 144    LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    158
TABLE 145    LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    158
TABLE 146    LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    158
TABLE 147    LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)    159
TABLE 148    LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)    159
TABLE 149    LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)    160
10.5.1    BRAZIL    160
10.5.1.1    Greater purchasing power and more favorable demographic conditions to drive market    160
TABLE 150    BRAZIL: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    160
TABLE 151    BRAZIL: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    161
TABLE 152    BRAZIL: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    161
TABLE 153    BRAZIL: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    161
10.5.2    MEXICO    162
10.5.2.1    Increased medical tourism and better government healthcare initiatives to drive market    162
TABLE 154    MEXICO: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    162
TABLE 155    MEXICO: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    162
TABLE 156    MEXICO: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    163
TABLE 157    MEXICO: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    163
10.5.3    REST OF LATIN AMERICA    163
TABLE 158    REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    164
TABLE 159    REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    164
TABLE 160    REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    165
TABLE 161    REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    165
10.6    MIDDLE EAST & AFRICA    165
10.6.1    GROWING MEDICAL TOURISM TO DRIVE MARKET    165
TABLE 162    MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)    166
TABLE 163    MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)    166
TABLE 164    MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)    167
TABLE 165    MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)    167
TABLE 166    MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)    167
TABLE 167    MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)    168
TABLE 168    MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)    168
11    COMPETITIVE LANDSCAPE    169
11.1    OVERVIEW    169
11.2    STRATEGIES ADOPTED BY KEY PLAYERS    169
11.2.1    OVERVIEW OF KEY STRATEGIES ADOPTED BY PLAYERS IN NEAR-INFRARED IMAGING MARKET    169
11.3    REVENUE SHARE ANALYSIS    169
FIGURE 28    REVENUE SHARE ANALYSIS OF TOP PLAYERS IN NEAR-INFRARED IMAGING MARKET, 2022    170
11.4    MARKET SHARE ANALYSIS    170
FIGURE 29    MARKET SHARE ANALYSIS OF TOP PLAYERS IN NEAR-INFRARED IMAGING MARKET, 2022    170
TABLE 169    NEAR-INFRARED IMAGING MARKET: DEGREE OF COMPETITION    171
11.5    COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)    172
11.5.1    STARS    172
11.5.2    EMERGING LEADERS    172
11.5.3    PERVASIVE PLAYERS    172
11.5.4    PARTICIPANTS    172
FIGURE 30    NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022    173
11.6    COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)    174
11.6.1    PROGRESSIVE COMPANIES    174
11.6.2    STARTING BLOCKS    174
11.6.3    RESPONSIVE COMPANIES    174
11.6.4    DYNAMIC COMPANIES    174
FIGURE 31    NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022    175
11.7    COMPETITIVE BENCHMARKING    176
TABLE 170    PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF KEY PLAYERS    176
TABLE 171    PRODUCT FOOTPRINT OF COMPANIES    176
TABLE 172    GEOGRAPHICAL FOOTPRINT OF COMPANIES    177
11.8    COMPETITIVE SCENARIOS AND TRENDS    178
TABLE 173    KEY PRODUCT LAUNCHES    178
TABLE 174    KEY DEALS    178
TABLE 175    OTHER KEY DEVELOPMENTS    179
12    COMPANY PROFILES    180
(Business overview, Products offered, Recent developments & MnM View)*
12.1    KEY PLAYERS    180
12.1.1    STRYKER    180
TABLE 176    STRYKER: COMPANY OVERVIEW    180
FIGURE 32    STRYKER: COMPANY SNAPSHOT (2022)    181
12.1.2    KARL STORZ SE & CO. KG    184
TABLE 177    KARL STORZ SE & CO. KG: COMPANY OVERVIEW    184
12.1.3    CARL ZEISS MEDITEC AG    186
TABLE 178    CARL ZEISS MEDITEC GROUP: COMPANY OVERVIEW    186
FIGURE 33    CARL ZEISS MEDITEC GROUP: COMPANY SNAPSHOT (2022)    187
12.1.4    LEICA MICROSYSTEMS    189
TABLE 179    LEICA MICROSYSTEMS: COMPANY OVERVIEW    189
FIGURE 34    LEICA MICROSYSTEMS (DANAHER CORPORATION): COMPANY SNAPSHOT (2022)    190
12.1.5    OLYMPUS CORPORATION    193
TABLE 180    OLYMPUS CORPORATION: COMPANY OVERVIEW    193
FIGURE 35    OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)    193
12.1.6    SHIMADZU CORPORATION    196
TABLE 181    SHIMADZU CORPORATION: COMPANY OVERVIEW    196
FIGURE 36    SHIMADZU CORPORATION: COMPANY SNAPSHOT (2021)    197
12.1.7    PERKINELMER, INC.    199
TABLE 182    PERKINELMER, INC.: COMPANY OVERVIEW    199
FIGURE 37    PERKINELMER, INC.: COMPANY SNAPSHOT (2021)    200
12.1.8    LI-COR, INC.    202
TABLE 183    LI-COR, INC.: COMPANY OVERVIEW    202
12.1.9    HAMAMATSU PHOTONICS K.K.    204
TABLE 184    HAMAMATSU PHOTONICS K.K.: COMPANY OVERVIEW    204
FIGURE 38    HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2022)    205
12.1.10    QUEST MEDICAL IMAGING B.V.    207
TABLE 185    QUEST MEDICAL IMAGING B.V.: COMPANY OVERVIEW    207
12.1.11    SIGMA-ALDRICH (MERCK)    208
TABLE 186    SIGMA-ALDRICH: COMPANY OVERVIEW    208
FIGURE 39    SIGMA-ALDRICH: COMPANY SNAPSHOT (2022)    208
12.1.12    MIZUHO MEDICAL CO., LTD.    210
TABLE 187    MIZUHO MEDICAL CO., LTD.: COMPANY OVERVIEW    210
12.1.13    TELEDYNE PRINCETON INSTRUMENTS    211
TABLE 188    TELEDYNE PRINCETON INSTRUMENTS: COMPANY OVERVIEW    211
FIGURE 40    TELEDYNE PRINCETON INSTRUMENTS: COMPANY SNAPSHOT (2022)    212
12.1.14    THERMO FISHER SCIENTIFIC INC.    213
TABLE 189    THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW    213
FIGURE 41    THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)    214
12.1.15    FLUOPTICS    216
TABLE 190    FLUOPTICS: COMPANY OVERVIEW    216
12.1.16    MEDTRONIC    217
TABLE 191    MEDTRONIC: COMPANY OVERVIEW    217
12.1.17    CAYMAN CHEMICAL    218
TABLE 192    CAYMAN CHEMICAL: COMPANY OVERVIEW    218
12.1.18    MP BIOMEDICALS    219
TABLE 193    MP BIOMEDICALS: COMPANY OVERVIEW    219
12.1.19    CRYSTA-LYN CHEMICAL COMPANY    220
TABLE 194    CRYSTA-LYN CHEMICAL COMPANY: COMPANY OVERVIEW    220
12.1.20    GOWERLABS LTD.    221
TABLE 195    GOWERLABS LTD.: COMPANY OVERVIEW    221
*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.
12.2    OTHER COMPANIES    222
12.2.1    NIRX MEDICAL TECHNOLOGIES, LLC    222
12.2.2    XENICS NV    222
12.2.3    BIOTIUM    223
12.2.4    TOKYO CHEMICAL INDUSTRY (INDIA) PVT. LTD.    224
12.2.5    AAT BIOQUEST, INC.    224

13    APPENDIX    225
13.1    DISCUSSION GUIDE    225
13.2    KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL    229
13.3    CUSTOMIZATION OPTIONS    231
13.4    RELATED REPORTS    231
13.5    AUTHOR DETAILS    232